Fahad M S Arattu Thodika1, Svilena Dimitrova2, Mahesh Nanjundappa2, Mark Davenport3, Kypros Nicolaides4, Theodore Dassios1,2, Anne Greenough5,6,7. 1. Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK. 2. Neonatal Intensive Care Centre, King's College Hospital NHS Foundation Trust, London, UK. 3. Department of Paediatric Surgery, King's College Hospital NHS Foundation Trust, London, UK. 4. Fetal Medicine Unit, King's College Hospital NHS Foundation Trust, London, UK. 5. Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK. anne.greenough@kcl.ac.uk. 6. Fetal Medicine Unit, King's College Hospital NHS Foundation Trust, London, UK. anne.greenough@kcl.ac.uk. 7. NIHR Biomedical Research Centre Based at Guy's and St Thomas NHS Foundation Trust and King's College London, London, UK. anne.greenough@kcl.ac.uk.
Abstract
The use of inhaled nitric oxide (iNO) in treating pulmonary hypertension in infants with congenital diaphragmatic hernia (CDH) is controversial. Our aims were to identify factors associated with survival in CDH infants and whether this was influenced by the response to iNO. Results of CDH infants treated in a tertiary surgical and medical perinatal centre in a ten year period (2011-2021) were reviewed. Factors affecting survival were determined. To assess the response to iNO, blood gases prior to and 30 to 60 min after initiation of iNO were analysed and PaO2/FiO2 ratios and oxygenation indices (OI) calculated. One hundred and five infants were admitted with CDH; 46 (43.8%) infants died. The CDH infants who died had a lower median observed to expected lung to head ratio (O/E LHR) (p < 0.001) and a higher median highest OI on day 1 (HOId1) (p < 0.001). HOId1 predicted survival after adjusting for gestational age, Apgar score at 5 min and O/E LHR (odds ratio 0.948 (95% confidence intervals 0.913-0.983)). Seventy-two infants (68.6%) received iNO; 28 survived to discharge. The median PaO2 (46.7 versus 58.8 mmHg, p < 0.001) and the median PaO2/FiO2 ratio (49.4 versus 58.8, p = 0.003) improved post iNO initiation. The percentage change in the PaO2/FiO2 ratio post iNO initiation was higher in infants who survived (69.4%) compared to infants who died (10.2%), p = 0.018. CONCLUSION: The highest OI on day 1 predicted survival. iNO improved oxygenation in certain CDH infants and a positive response was more likely in those who survived. WHAT IS KNOWN: • The use of iNO is controversial in infants with CDH with respect to whether it improves survival. WHAT IS NEW: • We have examined predictors of survival in CDH infants including the response to iNO and demonstrated that the highest oxygenation index on day 1 predicted survival (AUCROC =0.908). • Certain infants with CDH responded to iNO and those with a greater response were more likely to survive.
The use of inhaled nitric oxide (iNO) in treating pulmonary hypertension in infants with congenital diaphragmatic hernia (CDH) is controversial. Our aims were to identify factors associated with survival in CDH infants and whether this was influenced by the response to iNO. Results of CDH infants treated in a tertiary surgical and medical perinatal centre in a ten year period (2011-2021) were reviewed. Factors affecting survival were determined. To assess the response to iNO, blood gases prior to and 30 to 60 min after initiation of iNO were analysed and PaO2/FiO2 ratios and oxygenation indices (OI) calculated. One hundred and five infants were admitted with CDH; 46 (43.8%) infants died. The CDH infants who died had a lower median observed to expected lung to head ratio (O/E LHR) (p < 0.001) and a higher median highest OI on day 1 (HOId1) (p < 0.001). HOId1 predicted survival after adjusting for gestational age, Apgar score at 5 min and O/E LHR (odds ratio 0.948 (95% confidence intervals 0.913-0.983)). Seventy-two infants (68.6%) received iNO; 28 survived to discharge. The median PaO2 (46.7 versus 58.8 mmHg, p < 0.001) and the median PaO2/FiO2 ratio (49.4 versus 58.8, p = 0.003) improved post iNO initiation. The percentage change in the PaO2/FiO2 ratio post iNO initiation was higher in infants who survived (69.4%) compared to infants who died (10.2%), p = 0.018. CONCLUSION: The highest OI on day 1 predicted survival. iNO improved oxygenation in certain CDH infants and a positive response was more likely in those who survived. WHAT IS KNOWN: • The use of iNO is controversial in infants with CDH with respect to whether it improves survival. WHAT IS NEW: • We have examined predictors of survival in CDH infants including the response to iNO and demonstrated that the highest oxygenation index on day 1 predicted survival (AUCROC =0.908). • Certain infants with CDH responded to iNO and those with a greater response were more likely to survive.
Authors: J F Germain; C Farnoux; D Pinquier; A Cortez; J F Hartmann; O Sibony; P de Lagausie; F Beaufils Journal: J Pediatr Surg Date: 1996-12 Impact factor: 2.545
Authors: Kevin P Lally; Pamela A Lally; Robert E Lasky; Dick Tibboel; Tom Jaksic; Jay M Wilson; Bjorn Frenckner; Krista P Van Meurs; Desmond J Bohn; Carl F Davis; Ronald B Hirschl Journal: Pediatrics Date: 2007-09 Impact factor: 7.124
Authors: Cynthia D Downard; Tom Jaksic; Jennifer J Garza; Alexander Dzakovic; Luanne Nemes; Russell W Jennings; Jay M Wilson Journal: J Pediatr Surg Date: 2003-05 Impact factor: 2.545
Authors: Adesola C Akinkuotu; Stephanie M Cruz; Paulette I Abbas; Timothy C Lee; Stephen E Welty; Oluyinka O Olutoye; Christopher I Cassady; Amy R Mehollin-Ray; Rodrigo Ruano; Michael A Belfort; Darrell L Cass Journal: J Pediatr Surg Date: 2015-10-22 Impact factor: 2.545
Authors: Jan A Deprest; Alexandra Benachi; Eduard Gratacos; Kypros H Nicolaides; Christoph Berg; Nicola Persico; Michael Belfort; Glenn J Gardener; Yves Ville; Anthony Johnson; Francesco Morini; Mirosław Wielgoś; Ben Van Calster; Philip L J DeKoninck Journal: N Engl J Med Date: 2021-06-08 Impact factor: 176.079